The first one would be that CA 125 has additional prognostic information beyond the classical biomarkers of heart failure (BNP, NT-pro BNP); the addition of CA 125 to NT-pro BNP may be a superior tool of risk estimation than NT-pro BNP alone. Here, NPPB is linked to heart failure.